November 18, 2010 – The Society of Cardiovascular Computed Tomography (SCCT) has collaborated with the American College of Cardiology Foundation (ACCF), the American Heart Association (AHA) and other societies on the 2010 ACCF/AHA Guideline for assessing cardiovascular risk in asymptomatic adults. The guidelines were published at the American Heart Association’s Scientific Sessions.

November 18, 2010 – In the trial of 1,623 patients with coronary heart disease (CHD) or CHD risk equivalents, an investigational CETP inhibitor showed no significant differences from placebo in the primary safety measures studied. Researchers this week presented results from the phase III DEFINE study with Merck's CETP inhibitor, anacetrapib.

November 17, 2010 – A lunch symposium detailing the evidence for simulation in medical training and other fields will be sponsored by W.L. Gore and Associates at the VEITHsymposium. The EVEResT (European Virtual Reality Endovascular Research Team) lunch symposium will take place Nov. 19 from 12:00 to 1:00 p.m. in the Gramercy A room, second floor.

November 17, 2010 – Chronic heart failure patients treated with eplerenone (Inspra) experienced a significant reduction in risk of cardiovascular death or heart failure hospitalizations. The data comes from the EMPHASIS-HF trial, which compared Pfizer’s drug to placebo and standard therapy in patients with mild symptoms.

November 17, 2010 – Data from the ADVANCE bridge-to-heart-transplant study showed that 92 percent of patients were either alive on the implanted device, had a heart transplant or explanted for recovery. The study looked at the HeartWare Ventricular Assist System at 180 days.

November 17, 2010 – Atrial fibrillation (AFib) patients treated with catheter ablation reported fewer symptoms and improved quality of life, according to data from Circulation Cardiovascular Quality and Outcomes. The patients, who were treated with Biosense Webster’s NaviStar ThermoCool catheter, were compared with patients treated with antiarrhythmia drugs.

November 17, 2010 – A drug-eluting balloon (DEB) and a coronary stent have received CE mark approval in Europe. The DEB and the coronary CoCr stent, both by Blue Medical, have been approved for treating coronary diseases.

DEB therapy delivers a controlled dose of Paclitaxel to the coronary artery during balloon angioplasty.

November 17, 2010 - Results from the GRAVITAS Trial found that doubling the maintenance dose of clopidogrel (Plavix) did not reduce the risk of further ischemic events after percutaneous coronary intervention (PCI).

November 16, 2010 – A new tool for personalized preventative medicine was introduced at the American Heart Association Scientific Sessions 2010. Panasonic’s CardioHealth Station is designed to assist medical professionals in making a quick and valuable assessment of cardiovascular health.

November 16, 2010 – An all-in-one micropuncture radial access kit is now available in the United States. The Glidesheath Nitinol Kit, by Terumo Interventional Systems, is for physicians who prefer transradial interventional procedures.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now